Bionano Genomics (BNGO) Capital Expenditures (2017 - 2026)
Bionano Genomics (BNGO) reported Capital Expenditures of -$16000.0 for Q1 2026, up 95.15% on a YoY basis from -$8198.8 in Q1 2025, and down 104.85% sequentially from $330000.0 in Q2 2025.
Bionano Genomics (BNGO) Capital Expenditures (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 9 years of Capital Expenditures data on file, last reported at -$16000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 95.15% year-over-year to -$16000.0; the trailing twelve-month figure through Mar 2026 stood at $314000.0 (up 106.24% YoY), and the FY2024 full-year result was -$4.7 million, down 376.64% from the prior year.
- Capital Expenditures retreated to -$16000.0 in Q1 2026, from $330000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.6 million in Q4 2022 to a low of -$4.8 million in Q4 2024.
- A 5-year average of -$42500.0 and a median of $203500.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures surged 1227.63% in 2022 and sank 1369.23% in 2025, its largest moves.
- Tracing BNGO's Capital Expenditures over 5 years: stood at $1.6 million in 2022, then retreated by 18.96% to $1.3 million in 2023, then slumped by 480.35% to -$4.8 million in 2024, then surged by 106.9% to $330000.0 in 2025, then sank by 104.85% to -$16000.0 in 2026.
- Business Quant data shows BNGO's Capital Expenditures at -$16000.0 in Q1 2026, $330000.0 in Q2 2025, and -$330000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Dec 31, 2024 | -4.78 Mn |
| Dec 31, 2024 | -4.78 Mn |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | -256,000.00 |
| Jun 30, 2023 | -256,000.00 |
| Mar 31, 2023 | 360,000.00 |
| Mar 31, 2023 | 360,000.00 |